Lv52
880 积分 2023-07-12 加入
Control of Particulate Matter Contamination in Healthcare Manufacturing
16天前
已完结
Risk-based Strategy to Determine Testing Requirement for the Removal of Residual Process Reagents as Process-related Impurities in Bioprocesses
20天前
已完结
THPdb2: compilation of FDA approved therapeutic peptides and proteins
1个月前
已完结
Potency assignment of biotherapeutic reference standards
1个月前
已完结
Risk-Based Approach for Analytical Comparability and Comparability Protocols
2个月前
已完结
A survey of FDA Approved Monoclonal Antibodies and Fc-fusion Proteins for Manufacturing Changes and Comparability Assessment
2个月前
已完结
Risk-Based Comparability Assessment for Monoclonal Antibodies During Drug Development: A Clinical Pharmacology Perspective
2个月前
已完结
Pharmacokinetic, pharmacodynamic and immunogenicity comparability assessment strategies for monoclonal antibodies
2个月前
已完结
Pharmaceutical Preformulation and Formulation
3个月前
已完结
Basic regulatory science behind drug substance and drug product specifications of monoclonal antibodies and other protein therapeutics
3个月前
已完结
皖公网安备34019202002308
